false 2022 Q2 0001615165 --12-31 P2Y P4Y P5Y P5Y P5Y P1Y P5Y P1Y 0.09 0.39 0.71 1.33 2.12 0.15 1.97 P5Y P10Y P5Y P5Y P4Y P5Y P7Y 0.09 0.39 0.71 1.33 P0Y P0Y P2Y10M24D P5Y8M12D P1M6D P4Y2M12D P5Y P6Y1M6D 0.82 0.017 0.91 0.023 0.98 P6M P2Y 0.71 0.002 0.035 P6Y P6Y P6Y P5Y2M12D 0001615165 2022-01-01 2022-06-30 xbrli:shares 0001615165 2022-07-31 iso4217:USD 0001615165 2022-06-30 0001615165 2021-12-31 iso4217:USD xbrli:shares 0001615165 2022-04-01 2022-06-30 0001615165 2021-04-01 2021-06-30 0001615165 2021-01-01 2021-06-30 0001615165 us-gaap:CommonStockMember 2022-03-31 0001615165 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001615165 us-gaap:RetainedEarningsMember 2022-03-31 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001615165 2022-03-31 0001615165 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001615165 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001615165 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001615165 us-gaap:CommonStockMember 2022-06-30 0001615165 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001615165 us-gaap:RetainedEarningsMember 2022-06-30 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001615165 us-gaap:CommonStockMember 2021-12-31 0001615165 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001615165 us-gaap:RetainedEarningsMember 2021-12-31 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001615165 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2021-12-31 0001615165 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2021-12-31 0001615165 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001615165 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001615165 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001615165 us-gaap:CommonStockMember 2021-03-31 0001615165 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001615165 us-gaap:RetainedEarningsMember 2021-03-31 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001615165 2021-03-31 0001615165 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001615165 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001615165 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001615165 us-gaap:CommonStockMember 2021-06-30 0001615165 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001615165 us-gaap:RetainedEarningsMember 2021-06-30 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001615165 2021-06-30 0001615165 us-gaap:CommonStockMember 2020-12-31 0001615165 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001615165 us-gaap:RetainedEarningsMember 2020-12-31 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001615165 2020-12-31 0001615165 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001615165 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001615165 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001615165 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-06-30 0001615165 veri:VocaliDIncMember 2022-01-01 2022-06-30 0001615165 veri:March2022AcquisitionMember 2022-01-01 2022-06-30 0001615165 veri:PandologicsLtdMember 2022-01-01 2022-06-30 0001615165 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001615165 us-gaap:EmployeeStockMember 2022-01-01 2022-06-30 0001615165 us-gaap:PerformanceSharesMember 2022-01-01 2022-06-30 0001615165 srt:ScenarioPreviouslyReportedMember 2021-12-31 0001615165 srt:RestatementAdjustmentMember 2021-12-31 0001615165 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-12-31 0001615165 srt:RestatementAdjustmentMember 2021-01-01 2021-12-31 0001615165 2021-01-01 2021-12-31 0001615165 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001615165 srt:RestatementAdjustmentMember us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001615165 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001615165 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2021-12-31 0001615165 srt:RestatementAdjustmentMember us-gaap:RetainedEarningsMember 2021-12-31 0001615165 2020-01-01 2020-12-31 0001615165 veri:PandologicLtdMember 2022-01-01 2022-06-30 veri:Customer 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2021-06-30 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-06-30 xbrli:pure 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember srt:MinimumMember 2022-04-01 2022-06-30 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember srt:MinimumMember 2021-04-01 2021-06-30 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember srt:MinimumMember 2022-01-01 2022-06-30 0001615165 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember srt:MinimumMember 2021-01-01 2021-06-30 0001615165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember veri:CommercialEnterpriseMember 2022-01-01 2022-06-30 0001615165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember veri:CommercialEnterpriseMember 2021-01-01 2021-12-31 0001615165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember veri:CommercialEnterpriseMember srt:MinimumMember 2022-01-01 2022-06-30 0001615165 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember veri:CommercialEnterpriseMember srt:MinimumMember 2021-01-01 2021-12-31 0001615165 2022-07-01 2022-06-30 0001615165 veri:StockPurchaseAgreementMember veri:VocaliDIncMember 2022-06-10 2022-06-10 0001615165 veri:StockPurchaseAgreementMember veri:VocaliDIncMember 2022-06-10 0001615165 us-gaap:GeneralAndAdministrativeExpenseMember veri:VocaliDIncMember 2022-06-10 2022-06-10 0001615165 veri:VocaliDIncMember 2022-06-10 2022-06-10 0001615165 veri:VocaliDIncMember 2022-06-10 0001615165 veri:VocaliDIncMember us-gaap:DevelopedTechnologyRightsMember 2022-06-10 0001615165 veri:VocaliDIncMember us-gaap:DevelopedTechnologyRightsMember 2022-06-10 2022-06-10 0001615165 veri:SecuritiesPurchaseAgreementMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:SecuritiesPurchaseAgreementMember veri:March2022AcquisitionMember 2022-03-01 0001615165 veri:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:SecuritiesPurchaseAgreementMember srt:MaximumMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 us-gaap:GeneralAndAdministrativeExpenseMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:March2022AcquisitionMember 2022-03-01 0001615165 veri:March2022AcquisitionMember srt:MinimumMember 2022-03-01 2022-03-01 0001615165 veri:March2022AcquisitionMember srt:MaximumMember 2022-03-01 2022-03-01 0001615165 veri:InfluencerNetworkMember veri:March2022AcquisitionMember 2022-03-01 0001615165 us-gaap:TradeNamesMember veri:March2022AcquisitionMember 2022-03-01 0001615165 veri:BrandRelationshipsMember veri:March2022AcquisitionMember 2022-03-01 0001615165 veri:InfluencerNetworkMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 us-gaap:TradeNamesMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:BrandRelationshipsMember veri:March2022AcquisitionMember 2022-03-01 2022-03-01 0001615165 veri:PandologicsLtdMember veri:AgreementAndPlanOfMergerMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember veri:AgreementAndPlanOfMergerMember 2021-09-14 0001615165 veri:PandologicsLtdMember veri:AgreementAndPlanOfMergerMember us-gaap:CommonStockMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember veri:AgreementAndPlanOfMergerMember srt:MaximumMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember veri:ContingentConsiderationsMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember veri:RecognizedInCompensationExpenseWithinGeneralAndAdministrativeExpenseMember 2021-09-14 2021-09-14 0001615165 veri:PandologicsLtdMember us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001615165 veri:PandologicLtdMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember veri:ContingentConsiderationMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember 2021-09-14 0001615165 veri:PandologicLtdMember srt:MinimumMember 2022-01-01 2022-06-30 0001615165 veri:PandologicLtdMember srt:MaximumMember 2022-01-01 2022-06-30 0001615165 veri:PandologicLtdMember us-gaap:CustomerRelationshipsMember 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:DevelopedTechnologyRightsMember 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:TradeNamesMember 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:CustomerRelationshipsMember srt:MinimumMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:CustomerRelationshipsMember srt:MaximumMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:DevelopedTechnologyRightsMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember us-gaap:TradeNamesMember 2021-09-14 2021-09-14 0001615165 veri:PandologicLtdMember 2022-06-30 0001615165 veri:PandologicLtdMember country:IL 2022-01-01 2022-06-30 0001615165 veri:PandologicLtdMember country:IL 2021-09-14 2021-09-14 0001615165 veri:OnePointSevenFivePercentageConvertibleSeniorNotesDueTwoThousandTwentySixMember 2021-11-30 0001615165 veri:OnePointSevenFivePercentageConvertibleSeniorNotesDueTwoThousandTwentySixMember 2022-06-30 0001615165 veri:OnePointSevenFivePercentageConvertibleSeniorNotesDueTwoThousandTwentySixMember 2022-01-01 2022-06-30 veri:Day 0001615165 veri:OnePointSevenFivePercentageConvertibleSeniorNotesDueTwoThousandTwentySixMember 2021-11-01 2021-11-30 0001615165 veri:OnePointSevenFivePercentageConvertibleSeniorNotesDueTwoThousandTwentySixMember 2022-04-01 2022-06-30 0001615165 2021-11-01 2021-11-30 iso4217:USD veri:Derivative 0001615165 2021-11-16 0001615165 veri:EmployeeStockOptionAndRestrictedStockUnitsMember 2022-04-01 2022-06-30 0001615165 veri:EmployeeStockOptionAndRestrictedStockUnitsMember 2021-04-01 2021-06-30 0001615165 veri:EmployeeStockOptionAndRestrictedStockUnitsMember 2022-01-01 2022-06-30 0001615165 veri:EmployeeStockOptionAndRestrictedStockUnitsMember 2021-01-01 2021-06-30 0001615165 us-gaap:WarrantMember 2022-04-01 2022-06-30 0001615165 us-gaap:WarrantMember 2021-04-01 2021-06-30 0001615165 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001615165 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001615165 veri:CommonStockIssuableInConnectionWithConvertibleSeniorNotesMember 2022-04-01 2022-06-30 0001615165 veri:CommonStockIssuableInConnectionWithConvertibleSeniorNotesMember 2022-01-01 2022-06-30 0001615165 us-gaap:CashMember 2022-06-30 0001615165 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2022-06-30 0001615165 us-gaap:CashMember 2021-12-31 0001615165 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001615165 us-gaap:FairValueInputsLevel3Member veri:ContingentConsiderationLiabilityCurrentMember 2022-06-30 0001615165 us-gaap:FairValueInputsLevel3Member veri:ContingentConsiderationLiabilityNoncurrentMember 2022-06-30 0001615165 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001615165 us-gaap:FairValueInputsLevel3Member veri:ContingentConsiderationLiabilityCurrentMember 2021-12-31 0001615165 us-gaap:FairValueInputsLevel3Member veri:ContingentConsiderationLiabilityNoncurrentMember 2021-12-31 0001615165 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001615165 us-gaap:OtherNoncurrentAssetsMember 2022-06-30 0001615165 veri:SoftwareAndTechnologyMember 2022-01-01 2022-06-30 0001615165 veri:LicensedTechnologyMember 2022-01-01 2022-06-30 0001615165 us-gaap:DevelopedTechnologyRightsMember 2022-01-01 2022-06-30 0001615165 veri:CustomerAndSupplierRelationshipsMember 2022-01-01 2022-06-30 0001615165 us-gaap:NoncompeteAgreementsMember 2022-01-01 2022-06-30 0001615165 us-gaap:TradeNamesMember 2022-01-01 2022-06-30 0001615165 veri:SoftwareAndTechnologyMember 2022-06-30 0001615165 veri:LicensedTechnologyMember 2022-06-30 0001615165 us-gaap:DevelopedTechnologyRightsMember 2022-06-30 0001615165 veri:CustomerAndSupplierRelationshipsMember 2022-06-30 0001615165 us-gaap:NoncompeteAgreementsMember 2022-06-30 0001615165 us-gaap:TradeNamesMember 2022-06-30 0001615165 veri:SoftwareAndTechnologyMember 2021-12-31 0001615165 veri:LicensedTechnologyMember 2021-12-31 0001615165 us-gaap:DevelopedTechnologyRightsMember 2021-12-31 0001615165 veri:CustomerAndSupplierRelationshipsMember 2021-12-31 0001615165 us-gaap:NoncompeteAgreementsMember 2021-12-31 0001615165 us-gaap:TradeNamesMember 2021-12-31 0001615165 veri:AdvertisingCustomersMember 2022-06-30 0001615165 veri:AdvertisingCustomersMember 2021-12-31 0001615165 us-gaap:ManagementServiceMember 2022-06-30 0001615165 us-gaap:ManagementServiceMember 2021-12-31 0001615165 veri:SoftwareProductsAndServicesMember 2022-06-30 0001615165 veri:SoftwareProductsAndServicesMember 2021-12-31 0001615165 us-gaap:ProductAndServiceOtherMember 2022-06-30 0001615165 us-gaap:ProductAndServiceOtherMember 2021-12-31 0001615165 veri:CommercialEnterpriseMember 2022-04-01 2022-06-30 0001615165 veri:CommercialEnterpriseMember 2021-04-01 2021-06-30 0001615165 veri:CommercialEnterpriseMember 2022-01-01 2022-06-30 0001615165 veri:CommercialEnterpriseMember 2021-01-01 2021-06-30 0001615165 veri:GovernmentAndRegulatedEntitiesMember 2022-04-01 2022-06-30 0001615165 veri:GovernmentAndRegulatedEntitiesMember 2021-04-01 2021-06-30 0001615165 veri:GovernmentAndRegulatedEntitiesMember 2022-01-01 2022-06-30 0001615165 veri:GovernmentAndRegulatedEntitiesMember 2021-01-01 2021-06-30 0001615165 veri:SoftwareProductsAndServicesMember veri:CommercialEnterpriseMember 2022-04-01 2022-06-30 0001615165 veri:SoftwareProductsAndServicesMember veri:GovernmentAndRegulatedIndustriesMember 2022-04-01 2022-06-30 0001615165 veri:SoftwareProductsAndServicesMember 2022-04-01 2022-06-30 0001615165 veri:SoftwareProductsAndServicesMember veri:CommercialEnterpriseMember 2022-01-01 2022-06-30 0001615165 veri:SoftwareProductsAndServicesMember veri:GovernmentAndRegulatedIndustriesMember 2022-01-01 2022-06-30 0001615165 veri:SoftwareProductsAndServicesMember 2022-01-01 2022-06-30 0001615165 us-gaap:AdvertisingMember veri:CommercialEnterpriseMember 2022-04-01 2022-06-30 0001615165 us-gaap:AdvertisingMember 2022-04-01 2022-06-30 0001615165 us-gaap:AdvertisingMember veri:CommercialEnterpriseMember 2022-01-01 2022-06-30 0001615165 us-gaap:AdvertisingMember 2022-01-01 2022-06-30 0001615165 us-gaap:LicenseMember veri:CommercialEnterpriseMember 2022-04-01 2022-06-30 0001615165 us-gaap:LicenseMember 2022-04-01 2022-06-30 0001615165 us-gaap:LicenseMember veri:CommercialEnterpriseMember 2022-01-01 2022-06-30 0001615165 us-gaap:LicenseMember 2022-01-01 2022-06-30 0001615165 veri:ManagedServicesMember veri:CommercialEnterpriseMember 2022-04-01 2022-06-30 0001615165 veri:ManagedServicesMember 2022-04-01 2022-06-30 0001615165 veri:ManagedServicesMember veri:CommercialEnterpriseMember 2022-01-01 2022-06-30 0001615165 veri:ManagedServicesMember 2022-01-01 2022-06-30 0001615165 veri:CommercialEnterpriseMember 2022-04-01 2022-06-30 0001615165 veri:GovernmentAndRegulatedIndustriesMember 2022-04-01 2022-06-30 0001615165 veri:CommercialEnterpriseMember 2022-01-01 2022-06-30 0001615165 veri:GovernmentAndRegulatedIndustriesMember 2022-01-01 2022-06-30 0001615165 veri:SoftwareProductsServicesConsistsOfAiWARESaaSSolutionsMember 2022-04-01 2022-06-30 0001615165 veri:SoftwareProductsServicesConsistsOfAiWARESaaSSolutionsMember 2022-01-01 2022-06-30 0001615165 veri:SoftwareProductsAndServicesMember veri:PandologicLtdMember 2022-04-01 2022-06-30 0001615165 veri:SoftwareProductsAndServicesMember veri:PandologicLtdMember 2022-01-01 2022-06-30 0001615165 veri:SoftwareProductsAndServicesMember veri:CommercialEnterpriseMember 2021-04-01 2021-06-30 0001615165 veri:SoftwareProductsAndServicesMember veri:GovernmentAndRegulatedIndustriesMember 2021-04-01 2021-06-30 0001615165 veri:SoftwareProductsAndServicesMember 2021-04-01 2021-06-30 0001615165 veri:SoftwareProductsAndServicesMember veri:CommercialEnterpriseMember 2021-01-01 2021-06-30 0001615165 veri:SoftwareProductsAndServicesMember veri:GovernmentAndRegulatedIndustriesMember 2021-01-01 2021-06-30 0001615165 veri:SoftwareProductsAndServicesMember 2021-01-01 2021-06-30 0001615165 us-gaap:AdvertisingMember veri:CommercialEnterpriseMember 2021-04-01 2021-06-30 0001615165 us-gaap:AdvertisingMember 2021-04-01 2021-06-30 0001615165 us-gaap:AdvertisingMember veri:CommercialEnterpriseMember 2021-01-01 2021-06-30 0001615165 us-gaap:AdvertisingMember 2021-01-01 2021-06-30 0001615165 us-gaap:LicenseMember veri:CommercialEnterpriseMember 2021-04-01 2021-06-30 0001615165 us-gaap:LicenseMember 2021-04-01 2021-06-30 0001615165 us-gaap:LicenseMember veri:CommercialEnterpriseMember 2021-01-01 2021-06-30 0001615165 us-gaap:LicenseMember 2021-01-01 2021-06-30 0001615165 veri:ManagedServicesMember veri:CommercialEnterpriseMember 2021-04-01 2021-06-30 0001615165 veri:ManagedServicesMember 2021-04-01 2021-06-30 0001615165 veri:ManagedServicesMember veri:CommercialEnterpriseMember 2021-01-01 2021-06-30 0001615165 veri:ManagedServicesMember 2021-01-01 2021-06-30 0001615165 veri:CommercialEnterpriseMember 2021-04-01 2021-06-30 0001615165 veri:GovernmentAndRegulatedIndustriesMember 2021-04-01 2021-06-30 0001615165 veri:CommercialEnterpriseMember 2021-01-01 2021-06-30 0001615165 veri:GovernmentAndRegulatedIndustriesMember 2021-01-01 2021-06-30 0001615165 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2022-01-01 0001615165 2022-01-01 0001615165 srt:MinimumMember 2022-06-30 0001615165 srt:MaximumMember 2022-06-30 0001615165 srt:MinimumMember us-gaap:OtherAssetsMember 2022-06-30 0001615165 srt:MinimumMember veri:OtherAccruedLiabilitiesMember 2022-06-30 0001615165 us-gaap:OtherNoncurrentLiabilitiesMember 2022-06-30 utr:sqft 0001615165 veri:OfficeSubleaseMember 2021-02-01 2021-02-28 0001615165 veri:OfficeSubleaseMember 2021-01-01 2021-06-30 0001615165 veri:OfficeSubleaseMember 2022-04-01 2022-06-30 0001615165 veri:OfficeSubleaseMember 2022-01-01 2022-06-30 0001615165 veri:OfficeSubleaseMember 2021-04-01 2021-06-30 0001615165 veri:LeaseArrangementOneMember 2021-12-31 0001615165 veri:March2022AcquisitionMember 2022-06-30 0001615165 veri:VocaliDIncMember 2022-06-30 0001615165 veri:CommonStockAndEmployeeStockPurchasePlanMember 2022-01-01 2022-06-30 0001615165 veri:CommonStockAndEmployeeStockPurchasePlanMember 2021-01-01 2021-06-30 0001615165 us-gaap:CommonStockMember veri:MarchTwoThousandTwentyTwoAcquisitionMember 2022-01-01 2022-06-30 0001615165 us-gaap:CommonStockMember veri:PandologicLtdMember 2022-01-01 2022-06-30 0001615165 veri:TimebasedStockOptionMember 2022-01-01 2022-06-30 0001615165 us-gaap:StockOptionMember 2022-01-01 2022-06-30 0001615165 us-gaap:EmployeeStockMember srt:MinimumMember 2022-01-01 2022-06-30 0001615165 us-gaap:EmployeeStockMember srt:MaximumMember 2022-01-01 2022-06-30 0001615165 us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0001615165 us-gaap:RestrictedStockUnitsRSUMember 2021-04-01 2021-06-30 0001615165 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001615165 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-06-30 0001615165 veri:StockAwardsMember 2021-01-01 2021-06-30 0001615165 us-gaap:PerformanceSharesMember 2021-01-01 2021-06-30 0001615165 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001615165 us-gaap:EmployeeStockOptionMember 2021-04-01 2021-06-30 0001615165 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0001615165 us-gaap:EmployeeStockMember 2022-04-01 2022-06-30 0001615165 us-gaap:EmployeeStockMember 2021-04-01 2021-06-30 0001615165 us-gaap:EmployeeStockMember 2021-01-01 2021-06-30 0001615165 veri:CommonStockIssuedForServicesMember 2022-04-01 2022-06-30 0001615165 veri:CommonStockIssuedForServicesMember 2021-04-01 2021-06-30 0001615165 veri:CommonStockIssuedForServicesMember 2022-01-01 2022-06-30 0001615165 veri:CommonStockIssuedForServicesMember 2021-01-01 2021-06-30 0001615165 veri:CostOfRevenueMember 2022-04-01 2022-06-30 0001615165 veri:CostOfRevenueMember 2022-01-01 2022-06-30 0001615165 us-gaap:SellingAndMarketingExpenseMember 2022-04-01 2022-06-30 0001615165 us-gaap:SellingAndMarketingExpenseMember 2021-04-01 2021-06-30 0001615165 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-06-30 0001615165 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-06-30 0001615165 us-gaap:ResearchAndDevelopmentExpenseMember 2022-04-01 2022-06-30 0001615165 us-gaap:ResearchAndDevelopmentExpenseMember 2021-04-01 2021-06-30 0001615165 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-06-30 0001615165 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-06-30 0001615165 us-gaap:GeneralAndAdministrativeExpenseMember 2022-04-01 2022-06-30 0001615165 us-gaap:GeneralAndAdministrativeExpenseMember 2021-04-01 2021-06-30 0001615165 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-06-30 0001615165 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-06-30 0001615165 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001615165 us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0001615165 us-gaap:PerformanceSharesMember 2021-12-31 0001615165 us-gaap:PerformanceSharesMember 2022-06-30 0001615165 us-gaap:PerformanceSharesMember 2021-06-30 0001615165 us-gaap:EmployeeStockOptionMember 2021-12-31 0001615165 us-gaap:EmployeeStockOptionMember 2022-06-30 0001615165 veri:EmployeeStockPurchasePlanMember 2022-01-01 2022-06-30 0001615165 veri:EmployeeStockPurchasePlanMember 2022-06-30

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from       to       

Commission File Number: 001-38093

 

Veritone, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

47-1161641

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

2420 17th St., Office 3002, Denver, CO 80202

(Address of principal executive offices, including zip code)

(888) 507-1737

(Registrant’s telephone number, including area code)

 

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class

 

Trading Symbol

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

VERI

 

The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes   No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

 

Accelerated filer

Non-accelerated filer

 

 

Smaller reporting company

 

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2) of the Exchange Act.  Yes   No

As of July 31, 2022, 36,135,161 shares of the registrant’s common stock were outstanding.

 

 

 


 

VERITONE, INC.

QUARTERLY REPORT ON FORM 10-Q

June 30, 2022

TABLE OF CONTENTS

 

Special Note Regarding Forward-Looking Statements

 

1

PART I.

 

FINANCIAL INFORMATION

 

2

Item 1.

 

Financial Statements (Unaudited)

 

2

 

 

Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021

 

2

 

 

Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Six Months Ended June 30, 2022 and 2021

 

3

 

 

Condensed Consolidated Statements of Stockholders’ Equity for the Three and Six Months Ended June 30, 2022 and 2021

 

4

 

 

Condensed Consolidated Statements of Cash Flows for the Three and Six Months Ended June 30, 2022 and 2021

 

6

 

 

Notes to the Condensed Consolidated Financial Statements

 

7

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

27

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

38

Item 4.

 

Controls and Procedures

 

38

PART II.

 

OTHER INFORMATION

 

40

Item 1.

 

Legal Proceedings

 

40

Item 1A.

 

Risk Factors

 

40

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

40

Item 3.

 

Defaults Upon Senior Securities

 

40

Item 4.

 

Mine Safety Disclosures

 

40

Item 5.

 

Other Information

 

40

Item 6.

 

Exhibits

 

41

Signatures

 

42

 

 

 


 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements made in this Quarterly Report on Form 10-Q that are not historical or current facts may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “anticipates,” “believes,” “seeks,” “estimates,” “expects,” “intends,” “continue,” “can,” “may,” “plans,” “potential,” “projects,” “should,” “could,” “will,” “would” or similar expressions and the negatives of those expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Such forward-looking statements include, but are not limited to, any statements that refer to projections of our future financial condition and results of operations, capital needs and financing plans, competitive position, industry environment, potential growth and market opportunities, acquisition plans and strategies, compensation plans, governance structure and policies and/or the price of our common stock.

The forward-looking statements included herein represent our management’s current expectations and assumptions based on information available as of the date of this report. These statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Factors that may cause or contribute to such differences include, but are not limited to:

 

our ability to expand our aiWARE SaaS business;

 

 

declines or limited growth in the market for AI-based software applications and concerns over the use of AI that may hinder the adoption of AI technologies;

 

 

our requirements for additional capital to support our business growth, and the availability of such capital on acceptable terms, if at all;

 

 

our reliance upon a limited number of key customers for a significant portion of our revenue;

 

 

fluctuations in our results over time;

 

 

the impact of seasonality on our business;

 

 

our ability to manage our growth, including through acquisitions and our further expansion into international operations;

 

 

our ability to enhance our products and introduce new products that achieve market acceptance and keep pace with technological developments;

 

 

actions by our competitors, partners and others that may block us from using the technology in our aiWARE platform, offering it for free to the public or making it cost prohibitive to continue to incorporate their technologies into our platform;

 

 

interruptions, performance problems or security issues with our technology and infrastructure, or that of our third party service providers; and

 

 

any additional factors discussed in Item 2 (Management’s Discussion and Analysis of Financial Condition and Results of Operations) of Part I, and Item 1A (Risk Factors) of Part II, of this Quarterly Report on Form 10-Q, and in Item 1 (Business) and Item 1A (Risk Factors) of Part I of our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission (the “SEC”) on March 17, 2022, including future SEC filings.

Readers should carefully review these risks, as well as the additional risks described in other documents we file from time to time with the SEC. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations. In light of the significant risks and uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by us or any other person that such results will be achieved, and readers are cautioned not to place undue reliance on such forward-looking information, which speak only as of the date of this report.

Moreover, we operate in an evolving environment. New risks and uncertainties emerge from time to time and it is not possible for our management to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual future results to be materially different from those expressed or implied by any forward-looking statements.

Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. We qualify all of our forward-looking statements by these cautionary statements.

1


PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

VERITONE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share and share data)

(Unaudited)

 

 

 

As of

 

 

 

June 30,

 

 

December 31,

 

 

 

2022

 

 

2021

 

ASSETS

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

220,463

 

 

$

254,722

 

Accounts receivable, net

 

 

50,134

 

 

 

85,063

 

Expenditures billable to clients

 

 

17,975

 

 

 

27,180

 

Prepaid expenses and other current assets

 

 

14,365

 

 

 

12,117

 

Total current assets

 

 

302,937

 

 

 

379,082

 

Property, equipment and improvements, net

 

 

3,400

 

 

 

1,556

 

Intangible assets, net

 

 

89,370

 

 

 

93,872

 

Goodwill

 

 

45,787

 

 

 

42,028

 

Long-term restricted cash

 

 

856

 

 

 

855

 

Other assets

 

 

9,603

 

 

 

954

 

Total assets

 

$

451,953

 

 

$

518,347

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Accounts payable

 

$

30,213

 

 

$

46,711

 

Accrued media payments

 

 

81,569

 

 

 

86,923

 

Client advances

 

 

11,977

 

 

 

10,561

 

Contingent consideration, current

 

 

21,680

 

 

 

20,053

 

Other accrued liabilities

 

 

24,963

 

 

 

27,093

 

Total current liabilities

 

 

170,402

 

 

 

191,341

 

Convertible senior notes, non-current

 

 

195,681

 

 

 

195,082

 

Contingent consideration, non-current

 

 

305

 

 

 

31,533

 

Other non-current liabilities

 

 

15,344

 

 

 

13,891

 

Total liabilities

 

 

381,732

 

 

 

431,847

 

Commitments and contingencies (Note 9)

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

 

Common stock, par value $0.001 per share; 75,000,000 shares authorized; 36,128,363 and 34,972,256 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively

 

 

36

 

 

 

35

 

Additional paid-in capital

 

 

440,809

 

 

 

431,606

 

Accumulated deficit

 

 

(371,096

)

 

 

(345,037

)

Accumulated other comprehensive income (loss)

 

 

472

 

 

 

(104

)

Total stockholders' equity

 

 

70,221

 

 

 

86,500

 

Total liabilities and stockholders' equity

 

$

451,953

 

 

$

518,347

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2


VERITONE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE LOSS

(in thousands, except per share and share data)

(Unaudited)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenue

 

$

34,235

 

 

$

19,206

 

 

$

68,642

 

 

$

37,501

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

6,705

 

 

 

5,231

 

 

 

13,628

 

 

 

10,054

 

Sales and marketing

 

 

12,576

 

 

 

5,253

 

 

 

23,645

 

 

 

11,680

 

Research and development

 

 

11,068

 

 

 

4,646

 

 

 

20,951

 

 

 

9,606

 

General and administrative

 

 

2,304

 

 

 

15,644

 

 

 

24,625

 

 

 

47,187

 

Amortization

 

 

5,211

 

 

 

1,079

 

 

 

10,226

 

 

 

2,157

 

Total operating expenses

 

 

37,864

 

 

 

31,853

 

 

 

93,075

 

 

 

80,684

 

Loss from operations

 

 

(3,629

)

 

 

(12,647

)

 

 

(24,433

)

 

 

(43,183

)

Other expense, net

 

 

(1,231

)

 

 

(13

)

 

 

(2,417

)

 

 

(22

)

Loss before provision for income taxes

 

 

(4,860

)

 

 

(12,660

)

 

 

(26,850

)

 

 

(43,205

)

(Benefit from) provision for income taxes

 

 

(1,607

)

 

 

55

 

 

 

(1,468

)

 

 

77

 

Net loss

 

$

(3,253

)

 

$

(12,715

)

 

$

(25,382

)

 

$

(43,282

)

Net loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.09

)

 

$

(0.39

)

 

$

(0.71

)

 

$

(1.33

)

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

36,083,515

 

 

 

32,741,356

 

 

 

35,782,766

 

 

 

32,458,269

 

Comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(3,253

)

 

$

(12,715

)

 

$

(25,382

)

 

$

(43,282

)

Foreign currency translation gain, net of income taxes

 

 

386

 

 

 

 

 

 

576

 

 

 

7

 

Total comprehensive loss

 

$

(2,867

)

 

$

(12,715

)

 

$

(24,806

)

 

$

(43,275

)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3


VERITONE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands, except share amounts)

(Unaudited)

 

 

 

 

Three Months Ended June 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Accumulated

 

 

Comprehensive

 

 

 

 

 

 

 

Shares

 

 

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income

 

 

Total

 

Balance as of March 31, 2022

 

 

36,056,839

 

 

 

 

$

36

 

 

$

435,954

 

 

$

(367,843

)

 

$

86

 

 

$

68,233

 

Common stock issued under employee stock plans

 

 

78,802

 

 

 

 

 

 

 

 

212

 

 

 

 

 

 

 

 

 

212

 

Common stock withheld for employee taxes

 

 

(7,278

)

 

 

 

 

 

 

 

(72

)

 

 

 

 

 

 

 

 

(72

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

 

 

4,715

 

 

 

 

 

 

 

 

 

4,715

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,253

)

 

 

 

 

 

(3,253

)

Other comprehensive gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

386

 

 

 

386

 

Balance as of June 30, 2022

 

 

36,128,363

 

 

 

 

$

36

 

 

$

440,809

 

 

$

(371,096

)

 

$

472

 

 

$

70,221

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Accumulated

 

 

Comprehensive

 

 

 

 

 

 

 

Shares

 

 

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income

 

 

Total

 

Balance as of December 31, 2021

 

 

34,972,256

 

 

 

 

$

35

 

 

$

431,606

 

 

$

(345,037

)

 

$

(104

)

 

$

86,500

 

Cumulative-effect of accounting change adopted as of January 1, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

(677

)

 

 

 

 

 

(677

)

Common stock issued under employee stock plans, net

 

 

1,152,345

 

 

 

 

 

1

 

 

 

781

 

 

 

 

 

 

 

 

 

782

 

Common stock withheld for employee taxes

 

 

(465,118

)

 

 

 

 

 

 

 

(9,509

)

 

 

 

 

 

 

 

 

(9,509

)

Common stock issued for acquisition

 

 

116,550

 

 

 

 

 

 

 

 

1,929

 

 

 

 

 

 

 

 

 

1,929

 

Common stock issued as part of contingent consideration

 

 

352,330

 

 

 

 

 

 

 

 

6,440

 

 

 

 

 

 

 

 

 

6,440

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

 

 

9,562

 

 

 

 

 

 

 

 

 

9,562

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

(25,382

)

 

 

 

 

 

(25,382

)

Other comprehensive gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

576

 

 

 

576

 

Balance as of June 30, 2022

 

 

36,128,363

 

 

 

 

$

36

 

 

$

440,809

 

 

$

(371,096

)

 

$

472

 

 

$

70,221

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 


4


 

VERITONE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands, except share amounts)

(Unaudited)

 

 

 

 

 

Three Months Ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Accumulated

 

 

Comprehensive

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income

 

 

Total

 

Balance as of March 31, 2021

 

 

32,676,286

 

 

$

33

 

 

$

396,619

 

 

$

(310,932

)

 

$

73

 

 

$

85,793

 

Common stock issued under employee stock plans, net

 

 

194,481

 

 

 

 

 

 

540

 

 

 

 

 

 

 

 

 

540

 

Common stock issued for services

 

 

 

 

 

 

 

 

131

 

 

 

 

 

 

 

 

 

131

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

6,478

 

 

 

 

 

 

 

 

 

6,478

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(12,715

)

 

 

 

 

 

(12,715

)

Other comprehensive gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of June 30, 2021

 

 

32,870,767

 

 

$

33

 

 

$

403,768

 

 

$

(323,647

)

 

$

73

 

 

$

80,227

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Accumulated

 

 

Comprehensive

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income

 

 

Total

 

Balance as of December 31, 2020

 

 

31,799,354

 

 

$

32

 

 

$

368,477

 

 

$

(280,365

)

 

$

66

 

 

$

88,210

 

Common stock issued under employee stock plans, net

 

 

803,367